Meeting Minimum ESPEN Energy Recommendations Is Not Enough to Maintain Muscle Mass in Head and Neck Cancer Patients.
Adiposity
Adult
Aged
Aged, 80 and over
Body Composition
Cachexia
/ diagnostic imaging
Diet Records
Dietary Proteins
/ administration & dosage
Energy Intake
Female
Head and Neck Neoplasms
/ diagnostic imaging
Humans
Longitudinal Studies
Male
Middle Aged
Muscle, Skeletal
/ diagnostic imaging
Nutritional Status
Risk Factors
Tomography, X-Ray Computed
Treatment Outcome
Weight Loss
body composition
cachexia
computed tomography
dietary intake
head and neck cancer
skeletal muscle loss
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
12 Nov 2019
12 Nov 2019
Historique:
received:
16
09
2019
revised:
25
10
2019
accepted:
05
11
2019
entrez:
16
11
2019
pubmed:
16
11
2019
medline:
28
4
2020
Statut:
epublish
Résumé
The relationship between dietary intake and body composition changes during cancer treatment has not been well characterized. The aim of this study was to compare dietary intake at diagnosis and end of treatment in relation to changes in muscle mass and adiposity in head and neck cancer (HNC) patients. Dietary intakes (three-day food record) and body composition using computed tomography (CT) were assessed at diagnosis (baseline) and after treatment completion (post-treatment). Skeletal muscle (SM) loss was explored as a consequence of energy and protein intake in relation to the minimum and maximum European Society of Parenteral and Enteral Nutrition (ESPEN) guidelines. Higher energy intakes (kcal/kg/day) and increases in energy intake (%) from baseline to post-treatment were correlated with attenuated muscle loss (r = 0.62,
Identifiants
pubmed: 31726711
pii: nu11112743
doi: 10.3390/nu11112743
pmc: PMC6893412
pii:
doi:
Substances chimiques
Dietary Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Crit Rev Oncol Hematol. 2013 Aug;87(2):172-200
pubmed: 23746998
Head Neck. 2010 Mar;32(3):290-300
pubmed: 19626639
BMC Cancer. 2012 Oct 02;12:446
pubmed: 23031071
Am J Clin Nutr. 2014 May;99(5):999-1005
pubmed: 24572565
BMC Cancer. 2014 Sep 29;14:728
pubmed: 25266049
Clin Nutr. 2015 Jun;34(3):335-40
pubmed: 25799486
Br J Cancer. 2017 Jun 27;117(1):148-155
pubmed: 28588319
Head Neck. 2007 Oct;29(10):893-900
pubmed: 17405169
Front Oncol. 2018 Oct 22;8:457
pubmed: 30460194
J Pain Symptom Manage. 2012 Aug;44(2):181-91
pubmed: 22695045
Appl Physiol Nutr Metab. 2008 Oct;33(5):997-1006
pubmed: 18923576
Acta Oncol. 2013 Oct;52(7):1543-51
pubmed: 23964657
Clin Cancer Res. 2015 Apr 1;21(7):1734-40
pubmed: 25370466
Nutrition. 2001 May;17(5):438-42
pubmed: 11377146
Radiother Oncol. 2008 May;87(2):195-200
pubmed: 18342966
Semin Cell Dev Biol. 2016 Jun;54:2-10
pubmed: 26343952
Head Neck. 2016 Aug;38(8):1248-57
pubmed: 27028732
Cell Metab. 2012 Aug 8;16(2):153-66
pubmed: 22795476
Oral Oncol. 2016 Nov;62:28-33
pubmed: 27865369
Head Neck. 2013 May;35(5):695-703
pubmed: 22730077
Lancet Oncol. 2015 Jan;16(1):13-4
pubmed: 25524803
BMJ Support Palliat Care. 2018 Sep;8(3):258-265
pubmed: 29440149
J Clin Oncol. 2013 Apr 20;31(12):1539-47
pubmed: 23530101
Am J Clin Nutr. 2004 Aug;80(2):271-8
pubmed: 15277145
Clin Nutr. 2019 Feb 22;:null
pubmed: 30846324
Am J Clin Nutr. 2010 Sep;92(3):471-90
pubmed: 20729339
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
Nutrients. 2018 Sep 05;10(9):null
pubmed: 30189611
Anticancer Agents Med Chem. 2013 Oct;13(8):1197-203
pubmed: 23919745
Head Neck. 2011 Jun;33(6):863-70
pubmed: 20737491
Nat Rev Clin Oncol. 2013 Feb;10(2):90-9
pubmed: 23207794
Nutrients. 2014 Nov 19;6(11):5280-97
pubmed: 25415607
J Gerontol A Biol Sci Med Sci. 2011 Aug;66(8):888-95
pubmed: 21572082
Eur J Oncol Nurs. 2016 Jun;22:54-62
pubmed: 27179893
Cancer. 2011 Apr 15;117(8):1775-82
pubmed: 21360698